statistiche ricercatore

MORTARA, LORENZO

Distribuzione geografica

Continente	#
EU - Europa	13.834
NA - Nord America	13.431
AS - Asia	5.528
SA - Sud America	672
AF - Africa	79
OC - Oceania	27
Continente sconosciuto - Info sul continente non disponibili	18
AN - Antartide	1
Totale	33.590

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	13.238
IT - Italia	8.136
SG - Singapore	1.891
UA - Ucraina	1.796
CN - Cina	1.015
TR - Turchia	802
HK - Hong Kong	726
VN - Vietnam	719
SE - Svezia	688
DE - Germania	648
BR - Brasile	582
FI - Finlandia	537
IE - Irlanda	482
FR - Francia	422
GB - Regno Unito	336
RU - Federazione Russa	273
IN - India	117
NL - Olanda	114
CA - Canada	99
JP - Giappone	79
MX - Messico	77
PL - Polonia	69
ES - Italia	65
AR - Argentina	47
BD - Bangladesh	46
BE - Belgio	45
CH - Svizzera	43
AT - Austria	37
ZA - Sudafrica	32
CZ - Repubblica Ceca	31
IQ - Iraq	22
LT - Lituania	20
PT - Portogallo	17
AU - Australia	15
EC - Ecuador	14
EU - Europa	14
PK - Pakistan	13
ID - Indonesia	12
NZ - Nuova Zelanda	12
AE - Emirati Arabi Uniti	10
NO - Norvegia	10
RO - Romania	10
UZ - Uzbekistan	10
EG - Egitto	9
NG - Nigeria	9
CO - Colombia	8
SA - Arabia Saudita	8
CL - Cile	7
IL - Israele	7
MA - Marocco	7
MD - Moldavia	7
TH - Thailandia	7
BG - Bulgaria	6
GR - Grecia	6
KE - Kenya	6
PY - Paraguay	6
KZ - Kazakistan	5
MY - Malesia	5
TN - Tunisia	5
VE - Venezuela	5
HU - Ungheria	4
KR - Corea	4
NP - Nepal	4
RS - Serbia	4
AZ - Azerbaigian	3
BY - Bielorussia	3
DK - Danimarca	3
DZ - Algeria	3
EE - Estonia	3
IR - Iran	3
JO - Giordania	3
LB - Libano	3
LU - Lussemburgo	3
MK - Macedonia	3
SK - Slovacchia (Repubblica Slovacca)	3
SN - Senegal	3
A2 - ???statistics.table.value.countryCode.A2???	2
BA - Bosnia-Erzegovina	2
BB - Barbados	2
CR - Costa Rica	2
DM - Dominica	2
HN - Honduras	2
MC - Monaco	2
MT - Malta	2
PH - Filippine	2
PS - Palestinian Territory	2
SC - Seychelles	2
TT - Trinidad e Tobago	2
TW - Taiwan	2
XK - ???statistics.table.value.countryCode.XK???	2
AL - Albania	1
AQ - Antartide	1
BH - Bahrain	1
BN - Brunei Darussalam	1
BS - Bahamas	1
CG - Congo	1
CY - Cipro	1
DO - Repubblica Dominicana	1
GA - Gabon	1
GL - Groenlandia	1
Totale	33.574

Salva come PNG Salva come JPEG

Città	#
Milan	4.266
Jacksonville	1.342
Chandler	1.254
Singapore	1.059
Fairfield	1.025
Ashburn	947
Woodbridge	773
Hong Kong	722
Ann Arbor	629
Houston	537
Princeton	491
Dallas	479
Dublin	475
Wilmington	461
Dearborn	421
Beijing	410
Izmir	400
Rome	395
Nyköping	379
Seattle	358
Boardman	357
Como	322
Cambridge	317
Dong Ket	314
Los Angeles	225
The Dalles	221
New York	191
San Mateo	162
Chicago	157
Munich	100
San Diego	97
Kocaeli	93
London	85
Ogden	84
Turin	71
Helsinki	68
Santa Clara	67
São Paulo	67
Tokyo	66
Turku	60
Buffalo	57
Warsaw	52
Hefei	50
Ho Chi Minh City	50
Varese	49
Düsseldorf	48
Florence	48
Verona	48
Mexico City	46
Hanoi	45
Brussels	43
Kunming	40
Nanjing	40
Stockholm	37
Genoa	36
Guangzhou	34
Brooklyn	33
Chennai	33
Washington	33
Jinan	32
Frankfurt am Main	30
Manchester	30
Boston	29
Montreal	29
Norwalk	29
Bologna	28
Denver	27
Johannesburg	27
Salt Lake City	27
San Francisco	27
Toronto	26
Atlanta	25
Poplar	25
Phoenix	24
Brno	23
Pune	23
Bari	22
Nuremberg	22
Berlin	21
Vienna	21
Orem	20
Redmond	20
Des Moines	18
Palermo	17
Querétaro	17
Elk Grove Village	16
Naples	16
Amsterdam	15
Ankara	15
Belo Horizonte	15
Brescia	15
Shenyang	15
Fuzhou	14
Nanchang	14
Parma	14
Cavaria con Premezzo	13
Council Bluffs	13
Gallarate	13
Magnago	13
Pittsburgh	13
Totale	21.622

Salva come PNG Salva come JPEG

Nome	#
Allergie e intolleranze. Icone di immunopatologia.	2.651
Polarization of Tumor Infiltrating Leukocytes from Innate Immunity and their role in the Pro-angiogenic Phenotype in NSCLC	287
Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer	274
Natural killer cells from patients with malignant or inflammatory pleural effusions display decreased cytotoxicity and decidual NK-like phenotype	258
Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?	236
Can the co-dependence of the immune system and angiogenesis facilitate pharmacological targeting of tumours?	222
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells	221
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response	211
Grading of laboratories on CD4+T-lymphocyte evaluations based on acceptable data boundaries defined by the measurement error	210
Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization	208
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4(+) T lymphocytes for immunotherapy	206
Natural killer cells from patients with either malignant or inflammatory pleural effusions display decreased cytotoxic capacity and decidual-like phenotype	204
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies	203
DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus (SIVagm)	200
Natural killer cells as key players of tumor progression and angiogenesis: old and novel tools to divert their pro-tumor activities into potent anti-tumor effects	199
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS	198
Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review	195
Recognition of antigenic clusters of Candida albicans by T lymphocytes from human immunodeficiency virus-infected persons.	189
Positive role of macaque cytotoxic T lymphocytes during SIV infection: decrease of cellular viremia and increase of asymptomatic clinical period.	188
The human RNASET2 protein affects the polarization pattern of human macrophages in vitro	187
Proffered Paper: The pro-angiogenic phenotype of natural killer cells infiltrating squamous cell carcinoma lung cancer	185
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific anti-tumor memory	185
The therapeutic T-cell response induced by tumor delivery of TNF and melphalan is dependent on early triggering of natural killer and dendritic cells	184
Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.	183
Acetyl-L-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways	183
Orchestration of angiogenesis by immune cells	182
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions.	181
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection and specific anti-tumor memory.	180
Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication	179
T2 ribonuclease-mediated tumor suppression: an evolutionary conserved process involving a cross-talk between cancer cells and the immune system	179
Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: Implications for immunotherapy	177
The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer	176
CD56(bright)CD16(-) NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4(+) T Cell Proliferation	175
Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy	171
New strategies of mammary cancer vaccination	170
Myeloid derived suppressor cells interactions with natural killer cells and pro-angiogenic activities: roles in tumor progression	170
Analysis of the antigen specific T cell repertoire in HIV infection	170
Microenvironment-mediated regulation of cancer growth by the human RNASET2 oncosuppressor gene	170
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a TH1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory	167
Tumor vasculature targeted TNFα therapy: reversion of microenvironment anergy and enhancement of the anti-tumor efficiency.	167
Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene	167
Schedule-dependent therapeutic efficacy of L19mTNF-a and Melphalan combined with Gemcitabine	166
Tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells: a new paradigm in colorectal cancer angiogenesis	166
Early DC and NK cell activation during anticancer therapeutic response induced by TNFa tumor vessel delivery and melphalan	164
Analysis of Graves’ disease from the origins to the recent historical evolution	161
Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors	159
Selection of virus variants and emergence of virus escape mutants after immunization with epitope vaccine	158
The pro-angiogenic phenotype and functions of colorectal cancer tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells	158
Recognition of human T Leukaemia virus (HTLV-I) envelope by human CD4+ T cell lines from HTLV-I seronegative individuals: specificity and clonal heterogeneity.	156
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent antitumor preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.	156
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment	156
Early triggering of natural killer and dendritic cell during antitumor therapeutic response induced by TNFa tumor vessel delivery and melphalan	155
Regulation of macrophage differentiation and polarization pattern by human RNASET2 protein	154
The rnaset2 oncosuppressor protein regulates both differentiation and polarization in human macrophages	153
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation	152
Analyse de DC-SIGN dans un modèle de résistance au SIDA	150
Type 1 CD4+ T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptide vaccine in rhesus macaques.	144
Down syndrome, autoimmunity and T regulatory cells	140
A new strategy of tumor vaccination based on mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA	140
Analysis of a combined immunodeficiency patient with defect in MHCII expression (BLS) reveals the presence of several mutant isoforms of RFXANK mRNA	139
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy	139
Natural killer cells from pleural effusions are responsive to interleukin-2 but are endowed with a potent pro-angiogenic feature	139
Natural killer cells from malignant pleural effusion show a decidual-like phenotype and an alternative activatory state.	139
The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: a focus on innate immunity cells as therapeutic eﬀectors	139
A potential role of human RNASET2 overexpression in the pathogenesis of Graves’ disease	139
Plasmocytoid dendritic cell dynamics and alpha IFN production during Simian Immunodeficiency Virus infection with a nonpathogenic outcome	138
Biomedicine and traditional Chinese medicine: a fruitful scientific and cultural interaction.	138
Prostate cancer peripheral blood NK cells show enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 production, and secrete monocyte-recruiting and polarizing factors.	137
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent antitumor preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions	135
Natural killer cells infiltrating colo-rectal cancer are switched towards the decidual-like pro-angiogenic CD56brightCD16- NK cell subset	133
Pleural effusion NK cells from metastatic tumors display pro-angiogenic features and pleural effusion fluids block their response to IL-2 treatment	132
The oncosuppressive role of RNASET2 gene in a mouse tumor syngeneic model	132
Inhibition of Human T-Cell Leukemia virus type 2 (HTLV-2) replication by the suppressive action of CIITA and NF-Y	130
Antitumor vaccines and immunotherapeutic strategies based on CIITA-driven MHC class II espression in cancer cells.	130
Analysis of the selection pressure by the NEF-immunodominant macaque CTL response in SIV infection	130
STAT3 and STAT5 drive the pro-angiogenic NK cell polarization in colorectal cancer patients	130
Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves' disease patients during methimazole treatment	129
Early functional activation of natural killer cell and dendritic cell during the antitumor therapeutic response induced by TNFa tumor vessel delivery and melphalan	128
Tumor infiltrating (TINKs) and tumor associated (TANKs) from colorectal cancer patients are proangiogenic and express angiogenin and the MMP9-TIMP2, similar to decidual NK cells	128
Negative impact of high body mass index on cetuximab-mediated cellular cytotoxicity against human colon carcinoma cells	128
Therapy-induced antitumor vaccination by targeting tumor necrosis factor  to tumor vessels in combination with melphalan	127
Phenotypic and functional characterization of tumor infiltrating natural killer cells: role in tumor angiogenesis	126
Overexpression of Murine Rnaset2 in a Colon Syngeneic Mouse Carcinoma Model Leads to Rebalance of Intra-Tumor M1/M2 Macrophage Ratio, Activation of T Cells, Delayed Tumor Growth, and Rejection	126
CIITA-driven MHC-II+ tumor cells: preventive vaccines and superior generators of anti-tumor CD4+ T lymphocytes for immunotherapy.	125
Prolonged temporary remission in T1DM patients is associated to a distinctive Treg phenotype	124
Innate immunity driving tumor angiogenesis: the role of natural killer cells in non-small cell lung cancer (NSCLC)	124
Severità del Morbo di Basedow di prima diagnosi: ruolo dei linfociti Treg e dei micronutrienti. Dati preliminari di uno studio osservazionale pilota	124
The story of a vitamin for bone health that upgraded to hormone for systemic good health.	124
Tumor rejection and anti-tumor memory to neoplasias of different histotype genetically modified to express CIITA- autologous MHC class II genes. A new strategy of anti-tumor vaccination and tumor immunotherapy.	122
Targeted delivery of TNF-alpha to tumor vessels induces a strong cell-mediated immune response against homologous and heterologous tumors.	120
A new strategy of tumor vaccination based on tumor cells transduced with the MHC class II transactivator CIITA	120
Tumor targeted IL-2 and TNF alpha trigger a synergistic T cell-mediated therapeutic effect against mouse neuroblastoma.	120
Tumor treatment by TNF-alpha targeted to tumor vessels and melphalan induces strong adaptive immune response, protection from tumor growth and anti-tumor memory.	120
Functional and phenotypic characterization of tumor infiltrating NK cells.	120
CIITA-driven MHC class II expressing tumor cells of distinct hystotype act as a potent antitumor vaccine and as a superior generators of tumor-specific CD4+ T lymphocytes for immunotherapy.	120
Phenotype and function of myeloid dendritic cells derived from African green monkey blood monocytes	119
Inflammation, inflammatory cells and angiogenesis: decisions and indecisions	119
Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis	119
The MHC class II transactivator, CIITA, blocks the transcriptional activity of both HTLV-2 Tax-2 and HTLV-1 Tax-1	118
The MHC class II transactivator (CIITA): a physiologic inhibitor of HIV1 and HTLV2 retroviral infections	117
Totale	18.482

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	128.979
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	128.979

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	2.432	0	0	0	0	0	330	129	294	567	282	315	515
2021/2022	2.479	306	286	212	113	100	56	134	165	213	317	220	357
2022/2023	3.904	335	198	250	412	267	774	60	487	521	189	203	208
2023/2024	7.374	1.081	1.086	1.114	1.210	1.244	513	132	167	213	241	177	196
2024/2025	4.895	146	170	773	314	334	320	185	260	447	474	371	1.101
2025/2026	4.385	682	556	428	1.346	1.117	256	0	0	0	0	0	0
Totale													33.912